发明名称 Urea derivatives and their use as acat-inhibitors
摘要 Urea derivatives of formula (I), wherein R<1> is a group of formula (1) (in which R<4> is aryl which may have suitable substituent(s), or heterocyclic group which may have suitable substituent(s), and Y is bond, lower alkylene, -S-, -O-, (a), =CH-, -CONH-, (b), (in which R<7> is lower alkyl), -NHSO2-, -SO2NH-, -SO2NHCO- or -CONHSO2-); or thiazolyl, imidazolyl, pyrazolyl, pyridyl, thienyl, furyl, isoxazolyl or chromanyl, each of which may have suitable substituent(s); R<2> is lower alkyl, lower alkoxy(lower)alkyl, cycloalkyl, ar(lower)alkyl which may have suitable substituent(s), heterocyclic group or heterocyclic(lower)alkyl, R<3> is aryl which may have suitable substituent(s) or heterocyclic group which may have suitable substituent(s), and n is 0 or 1, and a pharmaceutically acceptable salt thereof which are useful as a medicament in the treatment of hypercholesterolemia, hyperlipidemia and atherosclerosis.
申请公布号 AU3577995(A) 申请公布日期 1996.04.26
申请号 AU19950035779 申请日期 1995.09.29
申请人 FUJISAWA PHARMACEUTICAL CO., LTD. 发明人 TAKESHI TERASAWA;AKIRA TANAKA;TOSHIYUKI CHIBA;HISASHI TAKASUGI
分类号 C07D295/12;A61K31/17;A61K31/18;A61K31/34;A61K31/35;A61K31/352;A61K31/357;A61K31/36;A61K31/38;A61K31/381;A61K31/395;A61K31/40;A61K31/415;A61K31/42;A61K31/421;A61K31/425;A61K31/426;A61K31/44;A61K31/4427;A61K31/443;A61K31/445;A61K31/495;A61K31/496;A61K31/505;A61K31/54;A61P3/06;A61P9/10;C07C275/26;C07C275/28;C07C275/30;C07C275/32;C07C275/38;C07C275/40;C07C275/42;C07C311/08;C07C311/21;C07C311/47;C07C311/51;C07C323/44;C07D207/32;C07D207/325;C07D211/14;C07D213/40;C07D213/70;C07D213/74;C07D213/75;C07D213/81;C07D231/12;C07D233/54;C07D233/61;C07D239/58;C07D249/08;C07D257/04;C07D261/08;C07D263/32;C07D271/10;C07D277/20;C07D277/28;C07D277/34;C07D295/135;C07D307/52;C07D311/58;C07D311/72;C07D317/58;C07D333/16;C07D333/20;C07D401/12;C07D403/12;C07D405/12;C07D417/12;C07D521/00 主分类号 C07D295/12
代理机构 代理人
主权项
地址